SALATA, CRISTIANO
 Distribuzione geografica
Continente #
NA - Nord America 14.562
AS - Asia 9.362
EU - Europa 5.864
SA - Sud America 1.428
AF - Africa 1.336
Continente sconosciuto - Info sul continente non disponibili 300
OC - Oceania 145
Totale 32.997
Nazione #
US - Stati Uniti d'America 13.695
SG - Singapore 2.938
IT - Italia 2.077
CN - Cina 1.605
VN - Vietnam 1.589
BR - Brasile 854
HK - Hong Kong 853
DE - Germania 466
FR - Francia 391
FI - Finlandia 360
BD - Bangladesh 331
PL - Polonia 326
NL - Olanda 316
IN - India 299
GB - Regno Unito 273
SE - Svezia 219
CA - Canada 197
JP - Giappone 164
TR - Turchia 164
UA - Ucraina 160
RU - Federazione Russa 153
AR - Argentina 145
IQ - Iraq 133
MX - Messico 103
PK - Pakistan 102
ZA - Sudafrica 101
PH - Filippine 98
ES - Italia 82
ID - Indonesia 78
AT - Austria 76
PT - Portogallo 73
CO - Colombia 70
KR - Corea 70
GR - Grecia 68
SA - Arabia Saudita 68
CH - Svizzera 64
AU - Australia 59
EC - Ecuador 58
PY - Paraguay 58
CI - Costa d'Avorio 57
MA - Marocco 55
AE - Emirati Arabi Uniti 54
VE - Venezuela 54
TN - Tunisia 53
CL - Cile 50
MY - Malesia 50
BJ - Benin 49
IE - Irlanda 49
AZ - Azerbaigian 48
CR - Costa Rica 47
TW - Taiwan 47
UZ - Uzbekistan 47
CZ - Repubblica Ceca 46
KZ - Kazakistan 46
AO - Angola 45
GH - Ghana 45
TH - Thailandia 45
GT - Guatemala 44
KE - Kenya 44
RO - Romania 44
NP - Nepal 43
EG - Egitto 42
IR - Iran 42
JM - Giamaica 42
NI - Nicaragua 42
PR - Porto Rico 41
UY - Uruguay 41
HN - Honduras 39
LB - Libano 39
BY - Bielorussia 38
PE - Perù 38
HU - Ungheria 36
JO - Giordania 35
SK - Slovacchia (Repubblica Slovacca) 35
AL - Albania 34
DZ - Algeria 34
GE - Georgia 34
BA - Bosnia-Erzegovina 33
DO - Repubblica Dominicana 33
ME - Montenegro 33
BB - Barbados 32
DK - Danimarca 32
ET - Etiopia 32
IL - Israele 32
LY - Libia 32
MR - Mauritania 32
NO - Norvegia 32
PS - Palestinian Territory 32
RE - Reunion 32
SO - Somalia 32
BO - Bolivia 31
EE - Estonia 31
LV - Lettonia 31
TZ - Tanzania 31
UG - Uganda 31
BE - Belgio 30
BF - Burkina Faso 30
BG - Bulgaria 30
KH - Cambogia 30
LA - Repubblica Popolare Democratica del Laos 30
Totale 31.334
Città #
Ashburn 1.826
Singapore 1.787
San Jose 1.699
Fairfield 866
Chandler 786
Woodbridge 780
Hong Kong 758
Houston 606
Ann Arbor 559
Jacksonville 466
Ho Chi Minh City 444
Santa Clara 402
Hanoi 371
Beijing 365
Seattle 349
Wilmington 328
Cambridge 315
Los Angeles 269
Boardman 253
Bytom 226
Dong Ket 226
Princeton 186
Padova 177
Milan 174
Lauterbourg 162
New York 160
Helsinki 159
Rome 157
Des Moines 140
Munich 136
Medford 131
San Diego 110
Council Bluffs 104
Roxbury 100
Nanjing 93
Chicago 77
The Dalles 77
Da Nang 75
São Paulo 75
Tokyo 74
Buffalo 70
Orem 63
Warsaw 62
Dallas 60
Haiphong 60
Abidjan 54
Hefei 54
Montreal 53
Vienna 53
Baghdad 52
Istanbul 51
Johannesburg 51
Brooklyn 49
Atlanta 48
Guangzhou 48
Turku 48
Cotonou 47
London 46
Padua 46
Toronto 46
Baku 45
Frankfurt am Main 45
Luanda 41
Chennai 40
Managua 40
Tashkent 39
Turin 39
Dublin 38
Lahore 37
Lisbon 37
Naples 37
Amsterdam 36
Nanchang 35
Denver 34
Montevideo 34
Accra 33
Guildford 33
Nairobi 33
Shanghai 33
Nuremberg 32
Phoenix 32
Amman 31
Bridgetown 31
Nouakchott 31
San José 31
Stockholm 30
Washington 30
Dakar 29
Noumea 29
Podgorica 29
Vientiane 29
Boston 28
Kingston 28
Lusaka 28
Ulan Bator 28
Bamako 27
Kampala 27
Rio de Janeiro 27
San Francisco 27
Falls Church 26
Totale 18.428
Nome #
Epidemiologia ed aspetti diagnostici dei Bunyavirus (Crimean-Congo Hemorrhagic Fever virus ed altri Bunyavirus meno noti) 910
Current distribution of arthropod of public health relevance in Italy: results from systematic reviews. 383
1,5-dicaffeoylquinic acid, from Onopordon illiricum, blocks EBOV replication counteracting the IFN-β production inhibition by the VP35 Ebola virus protein 338
IDENTIFICATION OF AN IMPORTANT FACTOR INVOLVED IN CCHFV INFECTION 318
Ebola Virus Entry: From Molecular Characterization to Drug Discovery 299
1,5-Dicaffeoylquinic Acid Blocks EBOV Replication Counteracting the IFN-beta Production Inhibition by the VP35 Ebola Virus Protein 299
SCREENING FOR TICK-BORNE AND TICK-ASSOCIATED VIRUSES IN TICKS COLLECTED IN SARDINIA, ITALY 291
Identification of druggable host dependency factors shared by multiple SARS-CoV-2 variants of concern 288
Amiodarone and metabolite MDEA inhibit Ebola virus infection by interfering with the viral entry process 286
Functional interaction between the ESCRT-I component TSG101 and the HSV-1 tegument ubiquitin specific protease 283
Amiodarone impairs trafficking through late endosomes inducing a Niemann-Pick C-like phenotype 275
A new inactive conformation of SARS-CoV-2 main protease 272
Role of the feline immunodeficiency virus L-domain in the presence or absence of Gag processing: involvement of ubiquitin and Nedd4-2s ligase in viral egress 266
IDENTIFICATION OF NEW SARS-COV-2 MAIN PROTEASE INHIBITORS BY AN INTEGRATED IN-SILICO AND IN-VITRO STRATEGY 265
Computationally driven discovery of SARS-CoV-2 Mpro inhibitors: from design to experimental validation 265
vOX2 glycoprotein of human herpesvirus 8 modulates human primary macrophages activity 263
The cranberry extract Oximacro® prevents Hazara virus infection by inhibiting the attachment to target cells 262
EVALUATION OF HAZARA VIRUS INFECTION IN ARTIFICIALLY INFECTED TICKS 261
Report of two cases of Influenza virus A/H1N1v and B co-infection during the 2010/2011 epidemics in the Italian Veneto Region 257
Generation of Combinatorial Lentiviral Vectors Expressing Multiple Anti-Hepatitis C Virus shRNAs and Their Validation on a Novel HCV Replicon Double Reporter Cell Line 257
IN VITRO ANTIVIRAL ACTIVITY OF EPIGALLOCATECHIN GALLATE AGAINST RABIES VIRUS 253
Artificial systems for ticks’ feeding and infection 253
Full genome sequence-based comparative study of wild-type and vaccine strains of infectious laryngotracheitis virus from Italy 251
Virus-Derived DNA Forms Mediate the Persistent Infection of Tick Cells by Hazara Virus and Crimean-Congo Hemorrhagic Fever Virus 249
Targeting host O-linked glycan biosynthesis affects Ebola virus replication efficiency and reveals differential GalNAc-T acceptor site preferences on the Ebola virus glycoprotein 248
SCREENING FOR CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS IN TICKS COLLECTED IN SARDINIA (ITALY) AND TUNISIA 246
Amiodarone increases positive-strand RNA virus replication in vitro: implications for its use in patients with viral infections 245
Intracellular trafficking and maturation of herpes simplex virus type 1 gB and virus egress require functional biogenesis of multivesicular bodies 244
IN VITRO ANTIVIRAL ACTIVITY OF A CRANBERRY VACCINIUM MACROCARPON EXTRACT AGAINST EBOLA VIRUS AND RABIES VIRUS 240
Antiviral activity of cationic amphiphilic drugs 239
Endometriotic Follicular Fluid Affects Granulosa Cells’ Morphology and Increases Duplication Rate and Connexin-43 Expression 237
Generation of combinatorial lentiviral vectors expressing multiple anti hepatitis C virus shRNAs and their validation on a novel HCV replicon double reporter cell line. 237
Rapid bedside inactivation of Ebola virus for safe nucleic acid tests 235
The deoxynucleoside triphosphate triphosphohydrolase activity of SAMHD1 protein contributes to the mitochondrial DNA depletion associated with genetic deficiency of deoxyguanosine kinase 230
Absence of class 1 and class 2 integrons among Campylobacter jejuni and Campylobacter coli isolated from poultry in Italy. 228
KINETICS OF HAZARA VIRUS REPLICATION IN ARTIFICIALLY INFECTED TICKS 227
Nef and cell signaling transduction: a possible involvement in the pathogenesis of human immunodeficiency virus-associated dementia 227
The Persistent Infection of Tick Cells by Hazara orthonairovirus Is Mediated by Virus-Derived DNA Forms 225
Sixth European seminar in virology on virus–host interaction at single cell and organism level 221
In vitro antiviral activity of hypothiocyanite against A/H1N1/2009 pandemic influenza virus 220
Human endogenous retroviruses and cancer prevention: evidence and prospects 219
Novel Broad-Spectrum Antiviral Inhibitors Targeting Host Factors Essential for Replication of Pathogenic RNA Viruses 217
Distribution and characterization of zoonotic Hepatitis E virus in wild ungulates hunted in North-Eastern Italy. 215
Highlights from the 5th Annual Meeting of the Italian Society of Virology 214
THE CRANBERRY (VACCINIUM MACROCARPON) EXTRACT BLOCKS EBOLA VIRUS AND CCHFV INFECTION BY INTERFERING WITH VIRAL ENTRY INTO TARGET CELLS. 211
Antimicrobial resistance and class 1 and 2 integrons in Escherichia coli from meat turkeys in Northern Italy 211
Involvement of p53 in specific anti-neuroectodermal tumor activity of aloe-emodin 210
Antiviral treatment and virological monitoring of oseltamivir resistant influenza virus A(H1N1)pdm09 in a patient with chronic B lymphocytic leukemia 210
Ten years of BSE surveillance in Italy: Neuropathological findings in clinically suspected cases 207
Feline tetherin is characterized by a short N-terminal region and is counteracted by the feline immunodeficiency virus envelope glycoprotein 207
A new generation of non-toxic tumor targeted anticancer agents 206
Antiviral treatment and virological monitoring of oseltamivir-resistant influenza virus A(H1N1)pdm09 in a patient with chronic B lymphocytic leukemia 199
New generation sequencing in pathogen discovery and microbial surveillance 196
Evaluation of the cellular pathway of Orthonairovirus infection in tick cell lines 196
Herpes simplex virus type 2 infection increases human immunodeficiency virus type 1 entry into human primary macrophages 195
Hazara virus and Crimean-Congo Hemorrhagic Fever Virus show a different pattern of entry in fully-polarized Caco-2 cell line 194
News and views from the 8th annual meeting of the Italian Society of Virology 193
Cranberry (Vaccinium macrocarpon) Extract Impairs Nairovirus Infection by Inhibiting the Attachment to Target Cells 193
ADAPTATION OF HAZARA ORTHONAIROVIRUS FOLLOWING FEW PASSAGES IN HYALOMMA-DERIVED TICK CELLS 192
The retrocyclin analogue RC-101 inhibits Ebola virus infection in vitro. 192
Hepatitis E virus infection in North Italy: high seroprevalence in swine herds and increased risk for swine workers 191
TSG101 interacts with Herpes simplex virus 1 VP1/2 and is a substrate of VP1/2 ubiquitin-specific protease domain activity 191
View and review on viral oncology research 188
Amiodarone inhibits Ebola virus infection by Blocking Viral Entry Into Target Cells Through Late Endosomes 188
Hypothiocyanite and Hypothiocyanite/Lactoferrin Mixture Exhibit Virucidal Activity In Vitro against SARS-CoV-2 188
The DEVD motif of Crimean-Congo hemorrhagic fever virus nucleoprotein is essential for viral replication in tick cells 186
Are Small Animal Practitioners Occupationally Exposed to Leptospirosis? Results of a Serological Survey 185
Development of an integrated geo-epidemiological system for the assessment of occupational risk of tick-borne pathogens. 184
vOX2 glycoprotein of Human Herpesvirus 8 modulates human primary macrophages activity 184
Production of influenza virus like particles by expression of engineered M1 proteins. 183
Analysis of Nef involvement in the development of HIV-1 Associated Dementia 183
Small RNAs targeting the 5' end of the viral polymerase gene segments specifically interfere with influenza type A virus replication 183
DEVELOPMENT OF A BSL-2 TOOL BASED ON THE PSEUDOTYPED VESICULAR STOMATITIS VIRUS TO STUDY CCHFV SERO-EPIDEMIOLOGY AND FOR ANTIVIRAL DISCOVERY 181
Aloe-emodine induce apoptosi nel neuroblastoma. Analisi dell'espressione genica 180
Update from the 7th annual meeting of the Italian Society of Virology 177
Vaccine-related influenza virus B infection in a child with an undiagnosed B-cell acute lymphoblastic leukemia 176
Multilocus sequence typing of Campylobacter jejuni and Campylobacter coli from humans and chickens in North-Eastern Italy. 176
Surveillance of influenza viruses circulating from 2017/2018 to 2023/2024 seasons in Veneto Region, North-East Italy 175
Generation of influenza virus like particles by expression of viral structural proteins. 175
HPRT mutant frequency and chromosomal aberrations induced by gamma and proton irradiations in human lymphocytes. 174
Terapia genica dei tumori: esperienza clinica e prospettive future 173
Effects of amiodarone on HSV-1 replication cycle: a new antiviral treatment? 171
HIV-1 Nef and cell signaling transduction: possible involvement in HIV-1 Associated Dementia (HAD) 171
Amiodarone affects Ebola virus binding and entry into target cells 171
Organoid modeling of Zika and herpes simplex virus 1 infections reveals virus-specific responses leading to microcephaly 171
Evaluation of UVC Excimer Lamp (222 nm) Efficacy for Coronavirus Inactivation in an Animal Model 169
Comparative analysis of Presence-Absence gene Variations in five hard tick species: impact and functional considerations 169
High prevalence of respiratory viruses co-infections in samples from hospitalized young children. 169
I cromosomi artificiali batterici per la caratterizzazione di geni di HSV-1 e lo sviluppo di vettori per il trasferimento genico 166
Identification and validation of internal reference genes for real-time quantitative polymerase chain reaction-based studies in Hyalomma anatolicum ticks 166
The persistent infection of tick cells by Hazara orthonairovirus is mediated by virus-derived DNA forms. 165
Impiego di virus oncolitici per la terapia genica dei tumori 163
Antiviral Properties of Amiodarone: More than a Pleyotropic Effect. 163
Summary of the 9th annual meeting of the Italian Society for Virology 163
Prevalenza dell’infezione da HEV in popolazione umana a rischio 162
First comparison of Campylobacter jejuni and Campylobacter coli isolated from humans and poultry in Italy: preliminary results. 162
Neutralizing Antibody Responses to SARS-CoV-2 in Recovered COVID-19 Patients Are Variable and Correlate With Disease Severity and Receptor-Binding Domain Recognition 162
Valutazione del ruolo della orf 74 dell'herpesvirus umano di tipo 8 (HHV-8) quale corecettore di HIV-1 161
Strategies for the optimization of influenza virus vaccine production 161
Aloe-emodin-induced apoptosis in neuroblastoma: analysis of gene expression 161
Totale 22.137
Categoria #
all - tutte 87.820
article - articoli 47.410
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 135.230


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.575 0 296 138 64 91 85 78 167 95 35 151 375
2022/20231.659 306 151 41 200 269 247 11 97 195 28 70 44
2023/20241.601 55 157 228 148 157 162 171 108 75 51 117 172
2024/20254.739 104 282 238 176 606 182 237 326 392 202 790 1.204
2025/202617.187 904 1.243 1.882 2.263 1.682 772 2.529 1.469 1.753 1.080 1.039 571
2026/2027961 692 269 0 0 0 0 0 0 0 0 0 0
Totale 32.997